Shaping the future of diabetes care - Roche

More documents

Recommendations

Info

Willy Michel Founder and Chairman, Disetronic r 14
Disetronic, the world’s No. 2 in insulin pumps Double digit sales and profitability growth • Disetronic Business HY 2002/ 03 vs HY 2001/ 02 – consolidated total sales 157 million CHF (+13.6 % in local currencies, +8.5 % in CHF) – net profit 29 m CHF (+35.5 %) – earnings per share 14.97 CHF (+34.6 %) – around 1,270 employees in EU and USA Injection Systems 24.1 % 75.9 % 2001/2002 sales mix r Infusions Systems - sales 115 m CHF - up by +9.2 % (local) - global market share ~30 % 15
Page 1 and 2: Shaping the future of diabetes care
Page 3 and 4: The idea Roche Diagnostics, the wor
Page 5 and 6: Strategic rationale Shaping the fut
Page 7 and 8: Diabetes: a problem of epidemic pro
Page 9 and 10: Glucose monitoring and insulin deli
Page 11 and 12: Roche adding marketing and sales mu
Page 13: Entry into insulin pump market Grow
Page 17 and 18: Business model with two elements br
Page 19 and 20: Proposed transaction structure r Ef
Page 21 and 22: Transaction multiples based upon th
Page 23 and 24: Public tender offer on Disetronic s
Page 25 and 26: About Roche Diabetes Care • Pione
Page 27 and 28: Diabetes is not curable, but it is

Shaping the future of diabetes care - Roche

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?